ESR1 — Estrogen Receptor Alpha

ESR1 — Estrogen Receptor Alpha

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">ESR1 — Estrogen Receptor Alpha</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>ESR1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>ESR1 — Estrogen Receptor Alpha</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=ESR1" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">448 edges</a></td>
</tr>
</table>

Pathway Diagram

ESR1 — Estrogen Receptor Alpha

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">ESR1 — Estrogen Receptor Alpha</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>ESR1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>ESR1 — Estrogen Receptor Alpha</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=ESR1" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">448 edges</a></td>
</tr>
</table>

Pathway Diagram

Introduction

Esr1 — Estrogen Receptor Alpha is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Official Symbol: ESR1 [@srvri2020] Official Full Name: Estrogen Receptor 1 [@gillman2019] Gene Type: Protein Coding [@tripanichkot2013] Location: Chromosome 6q25.1 [@dhandapani2005] NCBI Gene ID: 2099 [@cade2021] Ensembl ID: ENSG00000091831 [@liu2022] UniProt ID: P03372 [@azcoitia2023]

Overview

The Estrogen Receptor Alpha (ERα), encoded by the ESR1 gene, is a ligand-activated transcription factor that mediates the effects of estrogen hormones in the brain. ERα is widely expressed in brain regions involved in cognition, mood, and neuroprotection, including the [hippocampus](/brain-regions/hippocampus), [cortex](/brain-regions/cortex), hypothalamus, and amygdala. This receptor plays critical roles in neurodevelopment, synaptic plasticity, and protection against neurodegenerative processes.

Function

Estrogen Receptor Alpha functions through multiple mechanisms:

Genomic Signaling

• Direct Transcription Factor: Upon estrogen binding, ERα dimerizes and translocates to the nucleus, where it binds to estrogen response elements (EREs) in target gene promoters
• Co-regulator Recruitment: ERα recruits co-activator proteins (e.g., SRC-1, p300/CBP) to modulate gene expression
• Target Genes: Regulates genes involved in synaptic plasticity (BDNF, SYN1), antioxidant defense (GPX1, SOD1), and anti-apoptotic pathways (BCL2, MCL1)

Non-Genomic Signaling

• Rapid Signaling Events: ERα activates membrane-initiated signaling cascades within minutes of ligand binding
• PI3K/Akt Pathway: Stimulates neuroprotective Akt signaling
• MAPK/ERK Pathway: Activates ERK1/2 signaling involved in neuronal survival
• Calcium Homeostasis: Modulates [NMDA receptor](/entities/nmda-receptor) function and calcium signaling

Neuroprotective Mechanisms

• Anti-apoptotic: Upregulates BCL2 family proteins and inhibits caspase activation
• Anti-inflammatory: Suppresses microglial activation and pro-inflammatory cytokine production
• Antioxidant: Induces expression of antioxidant enzymes (SOD, GPX, catalase)
• Synaptic Plasticity: Promotes spine formation, [LTP](/mechanisms/long-term-potentiation), and cognitive function

Disease Associations

Alzheimer's Disease

• Risk Factor: Reduced ESR1 expression and signaling is associated with increased AD risk
• Therapeutic Target: ERα agonists (e.g., estradiol) have shown neuroprotective effects in preclinical models
• Clinical Trials: Estrogen therapy trials have yielded mixed results; timing and formulation are critical

Parkinson's Disease

• Neuroprotection: Estrogen attenuates dopaminergic neuron loss in animal models
• Clinical Correlation: Women have lower PD risk until menopause, suggesting protective role
• Therapeutic Potential: ERα-selective modifiers being explored

Stroke and Brain Injury

• Ischemic Protection: ERα mediates estrogen's protective effects in stroke models
• Traumatic Brain Injury: Reduced lesion size and improved recovery with ERα activation

Reproductive Disorders

• Breast Cancer: ESR1 is a major therapeutic target in hormone-receptor-positive breast cancer
• Endometriosis: Estrogen-driven condition treated with ER antagonists

Expression

Brain Regions

• Hippocampus: High expression in CA1, CA3, and dentate gyrus granule cells
• Cortex: Expressed in pyramidal [neurons](/entities/neurons) across all layers
• Hypothalamus: High expression in preoptic area and arcuate nucleus
• Amygdala: Present in various nuclei

Cell Types

• Neurons: Primary expression in excitatory glutamatergic neurons
• [Astrocytes](/entities/astrocytes): Expressed in subset of astrocytes
• [Microglia](/cell-types/microglia-neuroinflammation): Low baseline expression; upregulated in inflammation

Therapeutic Targeting

Agonists

• Estradiol (E2): Natural ligand, used in hormone therapy
• PPT (Propylpyrazoletriol): ERα-selective agonist
• Diarylpropionitrile (DPN): ERβ-selective agonist with brain penetration

Antagonists

• Tamoxifen: Selective estrogen receptor modulator (SERM)
• Ful: Pure ER antagonist
• CPP: ERα-selective antagonist

Clinical Considerations

• Timing Hypothesis: Critical window for estrogen therapy
• Dose-Dependent: Effects vary with dosing regimen
• Tissue Selectivity: SERMs offer tissue-specific effects

Background

The study of Esr1 — Estrogen Receptor Alpha has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• nuclear receptors
• [Antioxidant response](/mechanisms/oxidative-stress)
• [Neuroprotection](/mechanisms/neuroprotection)

External Links

• [NCBI Gene: ESR1](https://www.ncbi.nlm.nih.gov/gene/)
• [UniProt: Estrogen Receptor Alpha](https://www.uniprot.org/uniprotkb/)
• [Ensembl: ESR1](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving ESR1 — Estrogen Receptor Alpha discovered through SciDEX knowledge graph analysis: